{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:28:07Z","timestamp":1789583287172,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Heilongjiang Provincial Science Fund Project","award":["ZD2018020"],"award-info":[{"award-number":["ZD2018020"]}]},{"name":"Heilongjiang University of Traditional Chinese Medicine Graduate Innovation Research Project","award":["2019yjscx007"],"award-info":[{"award-number":["2019yjscx007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Ovarian cancer (OC) has been regarded as the most malignant gynecological neoplasm and often confers grave outcomes owing to the frequent metastasis and high recurrence. A previous study has demonstrated that miR-1271-5p is implicated in OC progression, however, the possible mechanism of it remains unknown. The purpose of this investigation was to explore how miR-1271-5p regulates the progression of OC.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were employed to analyze the differentially expressed miRNAs or genes as well as their corresponding prognostic values. miR-1271-5p expression in OC cells was examined by qRT-PCR. Cell counting kit 8 (CCK-8), colony formation, and transwell tests were conducted to evaluate the proliferation, migration and invasion potentials. Bioinformatics prediction and luciferase activity analysis were utilized to predict and verify the target gene of miR-1271-5p. Western blot assay was carried out to measure protein expression.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>miR-1271-5p was significantly decreased in OC and its down-regulation was associated with the grave outcome of OC patients. Upregulation of miR-1271-5p inhibited cell viability, but miR-1271-5p knockdown promoted the proliferation of OC cells. TIAM1 was a direct target gene of miR-1271-5p and expressed in OC tissues at higher level. High expression of TIAM1 induced the poorer prognosis of patients with OC. Further functional analyses showed that the suppressive role of miR-1271-5p on OC cell malignant behaviors was overturned by the upregulation of TIAM1. The protein levels of Cyclin D1, HES1, NOTCH and NUMB were remarkably changed due to the abnormal expression of miR-1271-5p and TIAM1.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>To sum up, miR-1271-5p inhibits proliferation, invasion and migration of OC cells by directly repressing TIAM1 to inactivate the Notch signaling pathway, which provides an alternative therapeutic candidate for the advancement of OC treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13048-020-00720-w","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T20:08:43Z","timestamp":1600459723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["microRNA-1271-5p\/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway"],"prefix":"10.1186","volume":"13","author":[{"given":"Feng-Juan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-5237","authenticated-orcid":false,"given":"Yan-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"720_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-8722-3-7","volume":"3","author":"B Liu","year":"2010","unstructured":"Liu B, et al. Ovarian cancer immunotherapy: opportunities, progresses and challenges. J Hematol Oncol. 2010;3:7.","journal-title":"J Hematol Oncol"},{"key":"720_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","volume":"44","author":"PB Ottevanger","year":"2017","unstructured":"Ottevanger PB. Ovarian cancer stem cells more questions than answers. Semin Cancer Biol. 2017;44:67\u201371.","journal-title":"Semin Cancer Biol"},{"issue":"suppl_8","key":"720_CR3","doi-asserted-by":"publisher","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","volume":"28","author":"EA Eisenhauer","year":"2017","unstructured":"Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann Oncol. 2017;28(suppl_8):viii61\u20135.","journal-title":"Ann Oncol"},{"issue":"4","key":"720_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"720_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.","journal-title":"Mol Cancer"},{"key":"720_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"G Di Leva","year":"2014","unstructured":"Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287\u2013314.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"720_CR7","first-page":"875","volume":"12","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP 3K3. Am J Transl Res. 2020;12(3):875\u201388.","journal-title":"Am J Transl Res"},{"key":"720_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1264-x","volume-title":"MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread","author":"PW Choi","year":"2020","unstructured":"Choi PW, et al. MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread; 2020."},{"issue":"3","key":"720_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s13205-020-2124-7","volume":"10","author":"N Paliwal","year":"2020","unstructured":"Paliwal N, Vashist M. Evaluation of miR-22 and miR-21 as diagnostic biomarkers in patients with epithelial ovarian cancer. 3 Biotech. 2020;10(3):142.","journal-title":"3 Biotech"},{"issue":"1","key":"720_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40659-020-00277-4","volume":"53","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene. Biol Res. 2020;53(1):10.","journal-title":"Biol Res"},{"issue":"2","key":"720_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","volume":"146","author":"N Liu","year":"2020","unstructured":"Liu N, et al. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis. J Cancer Res Clin Oncol. 2020;146(2):367\u201379.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"720_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbrc.2015.02.033","volume":"458","author":"Y Wang","year":"2015","unstructured":"Wang Y, Xu L, Jiang L. miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5. Biochem Biophys Res Commun. 2015;458(3):714\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"720_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096472","volume":"9","author":"L Wang","year":"2014","unstructured":"Wang L, et al. A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer. PLoS One. 2014;9(5):e96472.","journal-title":"PLoS One"},{"issue":"1","key":"720_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/geno.1999.5936","volume":"61","author":"CY Chiu","year":"1999","unstructured":"Chiu CY, et al. Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1. Genomics. 1999;61(1):66\u201373.","journal-title":"Genomics"},{"issue":"19","key":"720_CR15","doi-asserted-by":"publisher","first-page":"17559","DOI":"10.18632\/oncotarget.2755","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, et al. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget. 2015;6(19):17559\u201369.","journal-title":"Oncotarget"},{"issue":"8","key":"720_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.bjc.6603385","volume":"95","author":"R Engers","year":"2006","unstructured":"Engers R, et al. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer. 2006;95(8):1081\u20136.","journal-title":"Br J Cancer"},{"issue":"1","key":"720_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13058-016-0674-8","volume":"18","author":"K Xu","year":"2016","unstructured":"Xu K, et al. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res. 2016;18(1):14.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"720_CR18","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.3892\/ol.2016.5091","volume":"12","author":"H Li","year":"2016","unstructured":"Li H, et al. Clinical implication of Tiam1 overexpression in the prognosis of patients with serous ovarian carcinoma. Oncol Lett. 2016;12(5):3492\u20138.","journal-title":"Oncol Lett"},{"issue":"6","key":"720_CR19","first-page":"1835","volume":"27","author":"J Li","year":"2012","unstructured":"Li J, et al. Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncol Rep. 2012;27(6):1835\u201342.","journal-title":"Oncol Rep"},{"issue":"1","key":"720_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2008.09.030","volume":"279","author":"Z Wang","year":"2009","unstructured":"Wang Z, et al. Emerging role of notch in stem cells and cancer. Cancer Lett. 2009;279(1):8\u201312.","journal-title":"Cancer Lett"},{"issue":"5","key":"720_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/leu.2013.6","volume":"27","author":"M Colombo","year":"2013","unstructured":"Colombo M, et al. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes. Leukemia. 2013;27(5):1009\u201318.","journal-title":"Leukemia"},{"key":"720_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1749-6632.2003.tb03219.x","volume":"995","author":"CJ Shawber","year":"2003","unstructured":"Shawber CJ, et al. Notch signaling in primary endothelial cells. Ann N Y Acad Sci. 2003;995:162\u201370.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"720_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1158\/0008-5472.CAN-13-1686","volume":"74","author":"P Cheng","year":"2014","unstructured":"Cheng P, et al. Effects of notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Res. 2014;74(1):141\u201352.","journal-title":"Cancer Res"},{"issue":"2","key":"720_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2009.11.012","volume":"292","author":"Z Wang","year":"2010","unstructured":"Wang Z, et al. Cross-talk between miRNA and notch signaling pathways in tumor development and progression. Cancer Lett. 2010;292(2):141\u20138.","journal-title":"Cancer Lett"},{"key":"720_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jb\/mvz114","volume":"167","author":"HM Liu","year":"2019","unstructured":"Liu HM, et al. MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma. J Biochem. 2019;167:513\u201324.","journal-title":"J Biochem"},{"issue":"9","key":"720_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/JCMA.0000000000000145","volume":"82","author":"Y Yang","year":"2019","unstructured":"Yang Y, Chen L. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p\/HGF axis. J Chin Med Assoc. 2019;82(9):699\u2013709.","journal-title":"J Chin Med Assoc"},{"issue":"18","key":"720_CR27","first-page":"7989","volume":"23","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Eur Rev Med Pharmacol Sci. 2019;23(18):7989\u201399.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"720_CR28","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.2147\/OTT.S219018","volume":"12","author":"Y Jiao","year":"2019","unstructured":"Jiao Y, et al. miR-1271 inhibits growth, invasion and epithelial-mesenchymal transition by targeting ZEB1 in ovarian cancer cells. Onco Targets Ther. 2019;12:6973\u201380.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"720_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ygyno.2009.12.003","volume":"117","author":"SL Rose","year":"2010","unstructured":"Rose SL, et al. Notch 1 signaling is active in ovarian cancer. Gynecol Oncol. 2010;117(1):130\u20133.","journal-title":"Gynecol Oncol"},{"key":"720_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2018.10.006","volume":"213","author":"F Tian","year":"2018","unstructured":"Tian F, et al. Salidroside protects LPS-induced injury in human thyroid follicular epithelial cells by upregulation of MiR-27a. Life Sci. 2018;213:1\u20138.","journal-title":"Life Sci"},{"issue":"1","key":"720_CR31","first-page":"793","volume":"16","author":"Q Sun","year":"2018","unstructured":"Sun Q, et al. MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. Oncol Lett. 2018;16(1):793\u2013800.","journal-title":"Oncol Lett"},{"issue":"5","key":"720_CR32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4149\/neo_2016_506","volume":"63","author":"T Liang","year":"2016","unstructured":"Liang T, et al. MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1. Neoplasma. 2016;63(5):696\u2013704.","journal-title":"Neoplasma"},{"issue":"4","key":"720_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.18632\/oncotarget.1458","volume":"5","author":"MX Liu","year":"2014","unstructured":"Liu MX, et al. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer. Oncotarget. 2014;5(4):944\u201358.","journal-title":"Oncotarget"},{"issue":"5","key":"720_CR34","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.18632\/oncotarget.14152","volume":"8","author":"Z Feng","year":"2017","unstructured":"Feng Z, et al. Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer. Oncotarget. 2017;8(5):8215\u201325.","journal-title":"Oncotarget"},{"issue":"2","key":"720_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/IGC.0000000000000359","volume":"25","author":"AN Alniaimi","year":"2015","unstructured":"Alniaimi AN, et al. Increased Notch1 expression is associated with poor overall survival in patients with ovarian cancer. Int J Gynecol Cancer. 2015;25(2):208\u201313.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"720_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12038-016-9636-7","volume":"41","author":"C Dong","year":"2016","unstructured":"Dong C, et al. Long non-coding RNA HOTAIR regulates proliferation and invasion via activating notch signalling pathway in retinoblastoma. J Biosci. 2016;41(4):677\u201387.","journal-title":"J Biosci"},{"issue":"9","key":"720_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrurol.2014.195","volume":"11","author":"AN Flores","year":"2014","unstructured":"Flores AN, et al. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nat Rev Urol. 2014;11(9):499\u2013507.","journal-title":"Nat Rev Urol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-020-00720-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:28:09Z","timestamp":1631921289000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00720-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00720-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}